Search results
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 4 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 3 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for ...
Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi
Forbes· 4 days agoNovavax shares surged 132% to $10.41 as of 10:00 a.m. Friday morning, following an earlier surge in...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
The Conversation· 6 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU announcement was preceded by an application from AstraZeneca on March 27 2024 ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 4 days agoIn conclusion, Novavax Inc (NASDAQ:NVAX) is strategically maneuvering through financial and operational challenges by leveraging partnerships and refining its focus on core ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 4 days agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 3 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
News Highlights: Top Company News of the Day - Friday at 5 PM ET
Morningstar· 3 days agoA new podcast series examines what Meta Platforms' multibillion-dollar bet on the metaverse means for the company, investors and internet users. Bristol Myers Squibb said its trial& ...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 6 days agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 5 days agoThis development has been covered in various media outlets as primarily related to the known...